These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30726735)

  • 1. Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.
    Seth S; Li CY; Ho IL; Corti D; Loponte S; Sapio L; Del Poggetto E; Yen EY; Robinson FS; Peoples M; Karpinets T; Deem AK; Kumar T; Song X; Jiang S; Kang Y; Fleming J; Kim M; Zhang J; Maitra A; Heffernan TP; Giuliani V; Genovese G; Futreal A; Draetta GF; Carugo A; Viale A
    Cell Rep; 2019 Feb; 26(6):1518-1532.e9. PubMed ID: 30726735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal dominance defines metastatic dissemination in pancreatic cancer.
    Ho IL; Li CY; Wang F; Zhao L; Liu J; Yen EY; Dyke CA; Shah R; Liu Z; Çetin AO; Chu Y; Citron F; Attanasio S; Corti D; Darbaniyan F; Del Poggetto E; Loponte S; Liu J; Soeung M; Chen Z; Jiang S; Jiang H; Inoue A; Gao S; Deem A; Feng N; Ying H; Kim M; Giuliani V; Genovese G; Zhang J; Futreal A; Maitra A; Heffernan T; Wang L; Do KA; Gargiulo G; Draetta G; Carugo A; Lin R; Viale A
    Sci Adv; 2024 Mar; 10(11):eadd9342. PubMed ID: 38478609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational implications of tumor heterogeneity.
    Jamal-Hanjani M; Quezada SA; Larkin J; Swanton C
    Clin Cancer Res; 2015 Mar; 21(6):1258-66. PubMed ID: 25770293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment.
    Gutierrez C; Al'Khafaji AM; Brenner E; Johnson KE; Gohil SH; Lin Z; Knisbacher BA; Durrett RE; Li S; Parvin S; Biran A; Zhang W; Rassenti L; Kipps TJ; Livak KJ; Neuberg D; Letai A; Getz G; Wu CJ; Brock A
    Nat Cancer; 2021 Jul; 2(7):758-772. PubMed ID: 34939038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutionary determinants of cancer.
    Greaves M
    Cancer Discov; 2015 Aug; 5(8):806-20. PubMed ID: 26193902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
    Carugo A; Minelli R; Sapio L; Soeung M; Carbone F; Robinson FS; Tepper J; Chen Z; Lovisa S; Svelto M; Amin S; Srinivasan S; Del Poggetto E; Loponte S; Puca F; Dey P; Malouf GG; Su X; Li L; Lopez-Terrada D; Rakheja D; Lazar AJ; Netto GJ; Rao P; Sgambato A; Maitra A; Tripathi DN; Walker CL; Karam JA; Heffernan TP; Viale A; Roberts CWM; Msaouel P; Tannir NM; Draetta GF; Genovese G
    Cancer Cell; 2019 Feb; 35(2):204-220.e9. PubMed ID: 30753823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.
    Yao W; Rose JL; Wang W; Seth S; Jiang H; Taguchi A; Liu J; Yan L; Kapoor A; Hou P; Chen Z; Wang Q; Nezi L; Xu Z; Yao J; Hu B; Pettazzoni PF; Ho IL; Feng N; Ramamoorthy V; Jiang S; Deng P; Ma GJ; Den P; Tan Z; Zhang SX; Wang H; Wang YA; Deem AK; Fleming JB; Carugo A; Heffernan TP; Maitra A; Viale A; Ying H; Hanash S; DePinho RA; Draetta GF
    Nature; 2019 Apr; 568(7752):410-414. PubMed ID: 30918400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state.
    Echeverria GV; Ge Z; Seth S; Zhang X; Jeter-Jones S; Zhou X; Cai S; Tu Y; McCoy A; Peoples M; Sun Y; Qiu H; Chang Q; Bristow C; Carugo A; Shao J; Ma X; Harris A; Mundi P; Lau R; Ramamoorthy V; Wu Y; Alvarez MJ; Califano A; Moulder SL; Symmans WF; Marszalek JR; Heffernan TP; Chang JT; Piwnica-Worms H
    Sci Transl Med; 2019 Apr; 11(488):. PubMed ID: 30996079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.
    Tomihara H; Carbone F; Perelli L; Huang JK; Soeung M; Rose JL; Robinson FS; Lissanu Deribe Y; Feng N; Takeda M; Inoue A; Poggetto ED; Deem AK; Maitra A; Msaouel P; Tannir NM; Draetta GF; Viale A; Heffernan TP; Bristow CA; Carugo A; Genovese G
    Cancer Res; 2021 Jan; 81(2):332-343. PubMed ID: 33158812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma.
    Mottini C; Tomihara H; Carrella D; Lamolinara A; Iezzi M; Huang JK; Amoreo CA; Buglioni S; Manni I; Robinson FS; Minelli R; Kang Y; Fleming JB; Kim MP; Bristow CA; Trisciuoglio D; Iuliano A; Del Bufalo D; Di Bernardo D; Melisi D; Draetta GF; Ciliberto G; Carugo A; Cardone L
    Cancer Res; 2019 Nov; 79(21):5612-5625. PubMed ID: 31492820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas.
    Moncada R; Barkley D; Wagner F; Chiodin M; Devlin JC; Baron M; Hajdu CH; Simeone DM; Yanai I
    Nat Biotechnol; 2020 Mar; 38(3):333-342. PubMed ID: 31932730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.
    Elyada E; Bolisetty M; Laise P; Flynn WF; Courtois ET; Burkhart RA; Teinor JA; Belleau P; Biffi G; Lucito MS; Sivajothi S; Armstrong TD; Engle DD; Yu KH; Hao Y; Wolfgang CL; Park Y; Preall J; Jaffee EM; Califano A; Robson P; Tuveson DA
    Cancer Discov; 2019 Aug; 9(8):1102-1123. PubMed ID: 31197017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.
    Del Poggetto E; Ho IL; Balestrieri C; Yen EY; Zhang S; Citron F; Shah R; Corti D; Diaferia GR; Li CY; Loponte S; Carbone F; Hayakawa Y; Valenti G; Jiang S; Sapio L; Jiang H; Dey P; Gao S; Deem AK; Rose-John S; Yao W; Ying H; Rhim AD; Genovese G; Heffernan TP; Maitra A; Wang TC; Wang L; Draetta GF; Carugo A; Natoli G; Viale A
    Science; 2021 Sep; 373(6561):eabj0486. PubMed ID: 34529467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
    Le Compte M; De La Hoz EC; Peeters S; Fortes FR; Hermans C; Domen A; Smits E; Lardon F; Vandamme T; Lin A; Vanlanduit S; Roeyen G; Van Laere S; Prenen H; Peeters M; Deben C
    NPJ Precis Oncol; 2023 Dec; 7(1):128. PubMed ID: 38066116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal tracking in cancer and metastasis.
    Aalam SMM; Nguyen LV; Ritting ML; Kannan N
    Cancer Metastasis Rev; 2024 Jun; 43(2):639-656. PubMed ID: 37910295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling and specific targeting of gemcitabine-resistant subclones in heterogeneous pancreatic cancer cell populations.
    Färber B; Lapshyna O; Künstner A; Kohl M; Sauer T; Bichmann K; Heckelmann B; Watzelt J; Honselmann K; Bolm L; Ten Winkel M; Busch H; Ungefroren H; Keck T; Gemoll T; Wellner UF; Braun R
    Front Oncol; 2023; 13():1230382. PubMed ID: 37719017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and spontaneous metastasis assays can result in divergence in clonal architecture.
    Serrano A; Weber T; Berthelet J; El-Saafin F; Gadipally S; Charafe-Jauffret E; Ginestier C; Mariadason JM; Oakes SR; Britt K; Naik SH; Merino D
    Commun Biol; 2023 Aug; 6(1):821. PubMed ID: 37550477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential Chromogenic IHC: Spatial Analysis of Lymph Nodes Identifies Contact Interactions between Plasmacytoid Dendritic Cells and Plasmablasts.
    Claudio N; Nguyen MT; Wanner A; Pucci F
    Cancer Res Commun; 2023 Jul; 3(7):1237-1247. PubMed ID: 37484199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence microscopy imaging of mitochondrial metabolism in cancer cells.
    Gooz M; Maldonado EN
    Front Oncol; 2023; 13():1152553. PubMed ID: 37427141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer.
    Perelli L; Carbone F; Zhang L; Huang JK; Le C; Khan H; Citron F; Del Poggetto E; Gutschner T; Tomihara H; Soeung M; Minelli R; Srinivasan S; Peoples M; Lam TNA; Lundgren S; Xia R; Zhu C; Mohamed AMT; Zhang J; Sircar K; Sgambato A; Gao J; Jonasch E; Draetta GF; Futreal A; Bakouny Z; Van Allen EM; Choueiri T; Signoretti S; Msaouel P; Litchfield K; Turajlic S; Wang L; Chen YB; Di Natale RG; Hakimi AA; Giuliani V; Heffernan TP; Viale A; Bristow CA; Tannir NM; Carugo A; Genovese G
    Nat Cancer; 2023 Jul; 4(7):984-1000. PubMed ID: 37365326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.